Moderna
MRNA
#1112
Rank
NZ$36.91 B
Marketcap
NZ$93.08
Share price
0.70%
Change (1 day)
122.24%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$36.91 Billion

As of April 2026 Moderna has a market cap of NZ$36.91 Billion. This makes Moderna the world's 1112th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$36.91 B75.37%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Apr 20th, 2026 the market cap of Moderna was reported to be:

NZ$36.65 Billion
by Nasdaq info icon info icon
NZ$36.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$922.19 B 2,398.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$485.40 B 1,214.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$471.73 B 1,177.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.95 B-97.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.04 B-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.41 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$69.09 B 87.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$16.90 B-54.19%๐Ÿ‡บ๐Ÿ‡ธ USA